Literature DB >> 6253399

Virus excretion and neutralizing antibody response in saliva in human cytomegalovirus infection.

T Tamura, S Chiba, Y Chiba, T Nakao.   

Abstract

The local secretory immune mechanism in infants with cytomegalovirus infection was studied by a measurement of neutralizing antibody in saliva. Neutralizing antibodies were determined by the microculture plaque assay in 65 saliva specimens including 54 samples from cytomegalovirus-infected subjects and 11 from seronegative controls. In addition, cytomegalovirus isolation from saliva or urine or both and antibody determination in serum and saliva were simultaneously performed on seven infants with cytomegalovirus excretion over long periods. Results obtained were as follows. (i) Neutralizing antibodies were detected in 41 (76%) of 54 saliva specimens obtained from infected subjects but in none of the 11 seronegative controls. (ii) Neutralizing antibodies in saliva were of low titer but persistently detectable in all but one of the seven infants. No relationship was recognized between the cessation of virus excretion and the development of neutralizing antibodies in saliva. (iii) Virus-neutralizing activity was specifically found in the immunoglobulin A fraction of pooled saliva by diethylaminoethyl cellulose chromatography.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6253399      PMCID: PMC551206          DOI: 10.1128/iai.29.3.842-845.1980

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  11 in total

1.  Application of a microtechnique to viral serological investigations.

Authors:  J L SEVER
Journal:  J Immunol       Date:  1962-03       Impact factor: 5.422

2.  Cervical excretion cytomegalovirus: correlation with secretory and humoral antibody.

Authors:  J L Waner; D R Hopkins; T H Weller; E N Allred
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Virus excretion and antibody response in saliva in natural mumps.

Authors:  Y Chiba; K Horino; M Umetsu; Y Wataya; S Chiba
Journal:  Tohoku J Exp Med       Date:  1973-11       Impact factor: 1.848

4.  Microculture plaque assay for human and simian cytomegaloviruses.

Authors:  S Chiba; R L Striker; M Benyesh-Melnick
Journal:  Appl Microbiol       Date:  1972-04

Review 5.  The cytomegaloviruses: ubiquitous agents with protean clinical manifestations. II.

Authors:  T H Weller
Journal:  N Engl J Med       Date:  1971-07-29       Impact factor: 91.245

6.  Gamma-A-immunoglobulin from rabbit colostrum.

Authors:  J J Cebra; J B Robbins
Journal:  J Immunol       Date:  1966-07       Impact factor: 5.422

7.  The role of immunoglulins in the mechanism of mucosal immunity to virus infection.

Authors:  P L Ogra; D T Karzon
Journal:  Pediatr Clin North Am       Date:  1970-05       Impact factor: 3.278

8.  Human secretory immunoglobulins. 4. Quantitation of free secretory piece.

Authors:  P Brandtzaeg
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1971

9.  Strain-specific local and systemic cell-mediated immune responses to cytomegalovirus in humans.

Authors:  K R Beutner; A Morag; R Deibel; B Morag; D Raiken; P L Ogra
Journal:  Infect Immun       Date:  1978-04       Impact factor: 3.441

10.  CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS.

Authors:  T B TOMASI; E M TAN; A SOLOMON; R A PRENDERGAST
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307

View more
  7 in total

1.  Neutralizing activity of saliva against cytomegalovirus.

Authors:  Frances M Saccoccio; Mary K Gallagher; Stuart P Adler; Michael A McVoy
Journal:  Clin Vaccine Immunol       Date:  2011-07-27

Review 2.  Molecular biology and immunology of cytomegalovirus.

Authors:  P D Griffiths; J E Grundy
Journal:  Biochem J       Date:  1987-01-15       Impact factor: 3.857

3.  Effect of incubation temperature on isolation of cytomegalovirus from fresh clinical specimens.

Authors:  W W Gregory; M A Menegus
Journal:  J Clin Microbiol       Date:  1983-10       Impact factor: 5.948

4.  Cytomegalovirus-specific cell-mediated immunity in lower-socioeconomic-class adolescent women with local cytomegalovirus infections.

Authors:  R G Faix; S E Zweig; J F Kummer; D Moore; D J Lang
Journal:  J Clin Microbiol       Date:  1983-04       Impact factor: 5.948

5.  Development and validation of an assay to detect porcine reproductive and respiratory syndrome virus-specific neutralizing antibody titers in pig oral fluid samples.

Authors:  Kang Ouyang; Basavaraj Binjawadagi; Apisit Kittawornrat; Chris Olsen; Jagadish Hiremath; Nadia Elkalifa; Rose Schleappi; Jianmin Wu; Jeffrey Zimmerman; Gourapura J Renukaradhya
Journal:  Clin Vaccine Immunol       Date:  2013-06-19

6.  Antibody evasion by the N terminus of murid herpesvirus-4 glycoprotein B.

Authors:  Laurent Gillet; Philip G Stevenson
Journal:  EMBO J       Date:  2007-11-22       Impact factor: 11.598

Review 7.  Using the nonhuman primate model of HCMV to guide vaccine development.

Authors:  Jesse D Deere; Peter A Barry
Journal:  Viruses       Date:  2014-03-27       Impact factor: 5.048

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.